C12Y 306/04006
Vesicle-fusing atpase
Official title: Vesicle-fusing ATPase (3.6.4.6)
C12Y306/04006 (Vesicle-fusing atpase) appears on 8 US grants and 17 published applications in this corpus.
Search patents in C12Y- Granted patents
- 8
- Published applications
- 17
- Assignees
- 9
- Inventors
- 34
- Latest grant
- 10 Dec 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 0 | 1 |
| 2015 | 1 | 0 |
| 2016 | 1 | 2 |
| 2017 | 1 | 1 |
| 2018 | 1 | 0 |
| 2019 | 1 | 1 |
| 2020 | 1 | 2 |
| 2021 | 1 | 3 |
| 2022 | 0 | 0 |
| 2023 | 0 | 1 |
| 2024 | 1 | 0 |
| 2025 | 0 | 3 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Compositions and methods for predicting therapeutic outcome10 Dec 2024US 12,163,960 B2Washington University
- P97-IDS fusion proteins21 Sep 2021US 11,124,781 B2Bioasis Technologies, Inc.
- Fragments of P97 and uses thereof15 Sep 2020US 10,772,939 B2Bioasis Technologies, Inc.
- P97-IDS fusion proteins27 Aug 2019US 10,392,605 B2Bioasis Technologies, Inc.
- Fragments of P97 and uses thereof12 Jun 2018US 9,993,530 B2Bioasis Technologies, Inc.
- Vps4b inhibitor for use in methods for the treatment of hrd cancer10 Sep 2026US 2026/0265756 A1Institut Curie
- Methods and compositions for disrupting tau aggregates using polyserine repeat sequences targeting exogenous proteins3 Jul 2025US 2025/0215059 A1The Regents of the University of Colorado, a body corporate
- Compositions and methods for predicting therapeutic outcome20 Feb 2025US 2025/0060369 A1Washington University
- Engineered and chimeric nucleases2 Jan 2025US 2025/0002886 A1Metagenomi, Inc.
- Compositions and methods for inhibition and targeting of p9711 May 2023US 2023/0146923 A1California Institute of Technology
Most cited
By later US patents
- Fragments of p97 and uses thereof20US 9,364,567 B2Bioasis Technologies, Inc. · 2016
- P97-antibody conjugates and methods of use17US 9,150,846 B2Bioasis Technologies, Inc. · 2015
- P97-antibody conjugates and methods of use7US 9,850,472 B2Bioasis Technologies, Inc. · 2017
- Fragments of P97 and uses thereof7US 9,993,530 B2Bioasis Technologies, Inc. · 2018
- Fragments of P97 and uses thereof2US 10,772,939 B2Bioasis Technologies, Inc. · 2020